Radiation therapy oncology group P-0014: A phase 3 randomized study of patients with high-risk hormone-naive prostate cancer: Androgen blockade with 4 cycles of immediate chemotherapy versus androgen blockade with delayed chemotherapyPIENTA, Kenneth J.Urology (Ridgewood, NJ). 2003, Vol 62, Num 6B, pp 95-101, issn 0090-4295, 7 p.Article

Diagnosis and treatment of genitourinary malignanciesPIENTA, Kenneth J.Cancer treatment and research. 1996, Vol 88, issn 0927-3042, 274 p.Serial Issue

The conundrum of rising prostate-specific antigen: prevention and treatmentPIENTA, Kenneth J.Urology (Ridgewood, NJ). 2003, Vol 62, Num 6B, issn 0090-4295, 157 p.Serial Issue

Hormonal therapy options for patients with a rising prostate-specific antigen level after primary treatment for prostate cancerHELLERSTEDT, Beth.Urology (Ridgewood, NJ). 2003, Vol 62, Num 6B, pp 79-86, issn 0090-4295, 8 p.Article

Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing radiation treatment for prostate cancerPISANSKY, Thomas M.Urology (Ridgewood, NJ). 2003, Vol 62, Num 6B, pp 36-45, issn 0090-4295, 10 p.Article

Succesful separation between benign prostatic hyperplasia and prostate cancer by measurement of free and complexed PSALILJA, H; STENMAN, U.-H.Cancer treatment and research. 1996, Vol 88, pp 94-101, issn 0927-3042Article

Total androgen blockade for prostate cancer : the end does not justify the meansJAVLE, M; RAGHAVAN, D.Cancer treatment and research. 1996, Vol 88, pp 201-210, issn 0927-3042Article

The truth is out there: an overall perspective on androgen deprivationHELLERSTEDT, Beth A; PIENTA, Kenneth J.Urologic oncology. 2003, Vol 21, Num 4, pp 272-281, issn 1078-1439, 10 p.Article

Nontraditional Cancer TreatmentsMOYAD, Mark A; PIENTA, Kenneth J.Seminars in urologic oncology. 1999, Vol 17, Num 2, issn 1081-0943, 64 p.Serial Issue

Disrupting the Networks of CancerCAMACHO, Daniel F; PIENTA, Kenneth J.Clinical cancer research (Print). 2012, Vol 18, Num 10, pp 2801-2808, issn 1078-0432, 8 p.Article

Multiple Roles of Chemokine (C-C Motif) Ligand 2 in Promoting Prostate Cancer GrowthJIAN ZHANG; YI LU; PIENTA, Kenneth J et al.Journal of the National Cancer Institute. 2010, Vol 102, Num 8, pp 522-528, issn 0027-8874, 7 p.Article

Use of nomograms for predicting survival in patients with castrate prostate cancerGALSKY, Matt; KELLY, William Kevin.Urology (Ridgewood, NJ). 2003, Vol 62, Num 6B, pp 119-127, issn 0090-4295, 9 p.Article

Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancerPIENTA, Kenneth J.Seminars in oncology. 2001, Vol 28, Num 4, pp 3-7, issn 0093-7754, SUP15Article

Epidemiology of prostate cancer and bladder cancer : an overviewROSS, R. K.Cancer treatment and research. 1996, Vol 88, pp 1-11, issn 0927-3042Article

Current therapy for invasive bladder cancerMONTIE, J. E.Cancer treatment and research. 1996, Vol 88, pp 121-128, issn 0927-3042Article

Prostate cancer presenting as visual changesOLSON, Karin B; PIENTA, Kenneth J.Anticancer research. 2006, Vol 26, Num 1B, pp 755-758, issn 0250-7005, 4 p.Article

Mind-body effect: Insulinlike growth factor-1; clinical depression; and breast, prostate, and other cancer risk: An unmeasured and masked mediator of potential significance?MOYAD, Mark A; PIENTA, Kenneth J.Urology (Ridgewood, NJ). 2002, Vol 59, Num 4A, pp 4-8, issn 0090-4295Article

Retroperitoneal lymphadenectomy in staging and treatment of clinical stage I and II nonseminomatous testis cancer (NSGCT) : the development of nerve-sparing techniquesDONOHUE, J. P.Cancer treatment and research. 1996, Vol 88, pp 105-119, issn 0927-3042Article

Critical Appraisal of Prostate-specific Antigen in Prostate Cancer Screening: 20 Years LaterPIENTA, Kenneth J.Urology (Ridgewood, NJ). 2009, Vol 73, Num 5A, pp 11-20, issn 0090-4295, 10 p., SUPArticle

Salvage radiotherapy in the treatment of prostate cancerTSIEN, Christina; SANDLER, Howard.Urology (Ridgewood, NJ). 2003, Vol 62, Num 6B, pp 63-68, issn 0090-4295, 6 p.Article

New pathologic techniques for diagnosing genitourinary malignanciesWOJNO, K. J.Cancer treatment and research. 1996, Vol 88, pp 41-75, issn 0927-3042Article

Assessing health-related quality of life in patients with genitourinary malignanciesLITWIN, M. S.Cancer treatment and research. 1996, Vol 88, pp 249-264, issn 0927-3042Article

Hematopoietic Stem Cell Niche Is a Potential Therapeutic Target for Bone Metastatic TumorsSHIOZAWA, Yusuke; PIENTA, Kenneth J; TAICHMAN, Russell S et al.Clinical cancer research (Print). 2011, Vol 17, Num 17, pp 5553-5558, issn 1078-0432, 6 p.Article

Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancerDIBLASIO, Christopher J; KATTAN, Michael W.Urology (Ridgewood, NJ). 2003, Vol 62, Num 6B, pp 9-18, issn 0090-4295, 10 p.Article

The chemoprevention of prostate cancer and the prostate cancer prevention trialBRAWLEY, O. W; THOMPSON, I. M.Cancer treatment and research. 1996, Vol 88, pp 189-200, issn 0927-3042Article